Dive Brief: A wrist-worn wearable could provide early warning of the severe acute pain episodes that affect patients with sickle cell disease. Researchers at Children’s
Dive Brief: Glass Lewis is recommending that Masimo shareholders vote to elect two candidates nominated by activist investor Politan Capital Management to serve on the
Testosterone supplementation in men with low levels of the hormone did not increase the risk of heart attacks in a 5,246-patient study, allaying fears that
What could healthcare look like in 10, 20, or 30 years? What will be the future of healthcare? Will medical professionals make diagnoses with the
A chemical linked to a higher risk of leukemia and other blood cell cancers creeps into millions of homes whenever residents light their gas stoves.
Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose hemodiafiltration compared to those treated with
Tessa Therapeutics’ TT11X is a highly specialised CAR-T therapy that can kill cancer cells. Source: Shutterstock / SciePro Clinical-stage cell therapy company Tessa Therapeutics have
The company previously raised an undisclosed amount of capital as part of a Series A round, which featured investment from impact finance firm KOIS. Image
MSD will now work with the FDA to update Keytruda’s label. Source: Shutterstock / Atmosphere1. Merck (MSD) has announced updated results with Keytruda (pembrolizumab) in
The treatment combines Clearmind’s MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc’s Palmitoylethanolamide (PEA), the active ingredient of its proprietary CannAmide™ Tel